First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy

In 2017, a clinical trial of 37 subjects demonstrated that preschool peanut oral immunotherapy (P-OIT) was safe, with predominantly mild symptoms reported and only 1 moderate reaction requiring epinephrine. We sought to examine whether these findings would be applicable in a real-world setting. As p...

Full description

Saved in:
Bibliographic Details
Published inThe journal of allergy and clinical immunology in practice (Cambridge, MA) Vol. 7; no. 8; p. 2759
Main Authors Soller, Lianne, Abrams, Elissa M, Carr, Stuart, Kapur, Sandeep, Rex, Gregory A, Leo, Sara, Lidman, Per G, Yeung, Joanne, Vander Leek, Timothy K, McHenry, Mary, Wong, Tiffany, Cook, Victoria E, Hildebrand, Kyla J, Gerstner, Thomas V, Mak, Raymond, Lee, Nicole J, Cameron, Scott B, Chan, Edmond S
Format Journal Article
LanguageEnglish
Published United States 01.11.2019
Subjects
Online AccessGet more information

Cover

Loading…